Initial experience using the Axonics sacral neuromodulation system in patients with multiple sclerosis.
Annie ChenAnjali KapurSpencer MossackSteven J WeissbartJason M KimPublished in: Neurourology and urodynamics (2022)
The majority of MS patients reported significant initial improvement in UUI and associated quality of life measures on validated questionnaires after implantation of the Axonics System. Future studies are needed to determine the long-term outcomes and durability of this MRI full-body conditionally-safe system.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- magnetic resonance imaging
- multiple sclerosis
- mass spectrometry
- ms ms
- peritoneal dialysis
- contrast enhanced
- computed tomography
- current status
- magnetic resonance
- patient reported outcomes
- patient reported
- diffusion weighted imaging
- case control